KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 189 filers reported holding KRYSTAL BIOTECH INC in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $107,764 | +131.9% | 929 | +134.6% | 0.00% | – |
| Q2 2023 | $46,480 | +330.3% | 396 | +193.3% | 0.00% | – |
| Q1 2023 | $10,803 | +20.0% | 135 | +17.4% | 0.00% | – |
| Q4 2022 | $9,000 | +12.5% | 115 | +5.5% | 0.00% | – |
| Q3 2022 | $8,000 | +33.3% | 109 | +12.4% | 0.00% | – |
| Q2 2022 | $6,000 | -14.3% | 97 | -3.0% | 0.00% | – |
| Q1 2022 | $7,000 | – | 100 | +2400.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 4 | -99.4% | 0.00% | – |
| Q3 2021 | $32,000 | – | 619 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,003,367 | $232,390,572 | 11.06% |
| Frazier Life Sciences Management, L.P. | 988,460 | $114,661,360 | 7.62% |
| S Squared Technology, LLC | 108,215 | $12,552,940 | 6.77% |
| Avoro Capital Advisors LLC | 2,565,555 | $297,604,380 | 4.64% |
| APIS CAPITAL ADVISORS, LLC | 24,000 | $2,784,000 | 3.61% |
| Nicholas Investment Partners, LP | 355,611 | $41,250,876 | 3.08% |
| Ghost Tree Capital, LLC | 80,000 | $9,280,000 | 3.05% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 71,531 | $8,297,596 | 2.52% |
| Affinity Asset Advisors, LLC | 57,500 | $6,670,000 | 1.88% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 46,092 | $5,344,828 | 1.80% |